abagovomab 21
abciximab 22
abituzumab 18
abrilumab 16
actoxumab 11
adalimumab 14
aducanumab 8
afasevikumab 13
alacizumab_pegol 10
alemtuzumab 22
alirocumab 16
amatuximab 31
andecaliximab 18
anifrolumab 18
anrukinzumab 16
aprutumab 10
aprutumab_ixadotin 10
arcitumomab 20
ascrinvacumab 6
atezolizumab 14
atinumab 12
avelumab 10
basiliximab 20
bavituximab 28
begelomab 20
benralizumab 21
bevacizumab_beta 12
bezlotoxumab 11
bimagrumab 10
bleselumab 10
blinatumomab 28
blosozumab 25
bococizumab 13
brazikumab 10
brentuximab_vedotin 19
briakinumab 14
brodalumab 5
brolucizumab 21
brontictuzumab 16
burosumab 14
cabiralizumab 16
camrelizumab 10
canakinumab 20
cantuzumab_ravtansin 38
carlumab 11
carotuximab 21
cergutuzumab_amunaleukin2 21
cergutuzumab_amunaleukin 21
certolizumab_pegol 19
cetiximab 35
citatuzumab_bogatox 24
cixutumumab 18
clivatuzumab_tetraxetan 13
codrituzumab 26
conatumumab 6
concizumab 25
crenezumab 16
crizanlizumab 18
crotedumab 14
dacetuzumab 18
daclizumab 10
dalotuzumab 25
dapirolizumab_pegol 21
daratumumab 13
dectrekumab 8
demcizumab 17
denosumab 10
depatuxizumab 17
depatuxizumab_mafodotin 17
dezamizumab 16
dinutuximab 31
diridavumab 13
domagrozumab 13
drozitumab 12
duligotuzumab 18
durvalumab 4
dusigitumab 3
efalizumab 27
efungumab 24
eldelumab 10
elezanumab 12
elgemtumab 8
elotuzumab 10
emactuzumab 15
emapalumab 22
emibetuzumab 11
enavatuzumab 23
enfortumab_vedotin 8
enoblituzumab 15
enokizumab 18
enoticumab 14
ensituximab 26
eptinezumab 17
erenumab 13
etaracizumab 14
etrolizumab 18
evinacumab 20
evolocumab 4
farletuzumab 4
fasinumab 18
fezakinumab 11
fibatuzumab 5
ficlatuzumab 14
firivumab 28
flanvotumab 14
fletikumab 13
foralumab 8
foravirumab 11
fremanezumab 22
fresolimumab 16
fulranumab 18
futuximab 11
galcanezumab 13
ganitumab 23
gantenerumab 10
gemetuzumab 21
gemtuzumab2 21
gemtuzumab 18
gevokizumab 19
girentuximab 19
glembatumumab 13
glembatumumab_vedotin 13
guselkumab 19
ibalizumab 20
ibritumomab 25
icrucumab 6
idarucizumab 22
ifabotuzumab 5
imalumab 14
imgatuzumab 15
inclacumab 10
indatuximab_ravtansin 23
indusatumab 8
inebilizumab 21
intetumumab 8
iodine_girentuximab 25
ipilimumab 3
iratumumab 6
isatuximab 30
itolizumab 22
ixekizumab 27
labetuzumab_govitecan 15
lambrolizumab 18
lampalizumab 19
lanadelumab 15
landogrozumab 16
laprituximab 21
lebrikizumab 32
lendalizumab 20
lenzilumab 9
lifastuzumab_vedotin 21
ligelizumab 19
lilotomab 31
lirilumab 12
lodelcizumab 10
lokivetmab 22
lorvotuzumab_mertansin 17
lucatumumab 25
lumretuzumab 10
lupartumab 7
lutikizumab 18
margetuximab 27
milatuzumab 29
mirvetuximab 25
mirvetuximab_soravtansin 25
modotuximab 27
mogamulizumab 26
monalizumab 15
motavizumab 24
moxetumomab_pasudotox 24
namilumab 11
naratuximab 22
naratuximab_emtansin 22
narnatumab 12
navicixizumab2 23
navicixizumab 19
navivumab 28
necitumumab 8
nemolizumab 19
nesvacumab 13
nivolumab 10
obiltoxaximab 16
obinutuzumab 30
ocaratuzumab 25
ofatumumab 12
olaratumab 10
olokizumab 21
omalizumab 17
onartuzumab 18
ontuxizumab 16
opicinumab 13
orticumab 9
otelixizumab 30
oxelumab 9
ozanezumab 24
pamrevlumab 6
panobacumab 16
parsatuzumab 19
pasotuxizumab 20
pateclizumab 13
patritumab 14
pembrolizumab 18
perakizumab 13
pidilizumab 16
pinatuzumab_vedotin 14
plozalizumab 23
pogalizumab 21
polatuzumab_vedotin 18
ponezumab 31
prezalumab 12
pritoxaximab 24
quilizumab 17
racotumomab 17
radretumab 13
ralpancizumab 18
ramucirumab 13
ranevetmab 17
ranibizumab 16
refanezumab 18
remtolumab 13
rilotumumab 9
rinucumab 14
risankizumab 31
rituximab 16
rivabazumab 13
robatumumab 19
roledumab 22
romosozumab 17
rontalizumab 19
rosmantuzumab 18
rozanolixizumab 16
sacituzumab 15
sacituzumab_govitecan 15
samalizumab 17
sapelizumab 20
sarilumab 10
secukinumab 8
seribantumab 14
setoxaximab 36
sifalimumab 5
siltuximab 22
simtuzumab 23
sirukumab 7
solanezumab 19
solitomab 15
stamulumab 13
suptavumab 14
suvizumab 13
tabalumab 8
tadocizumab 11
tamtuvetmab 29
tanezumab 20
tarextumab 7
tavolixizumab 13
telisotuzumab 25
teplizumab 15
tesidolumab 14
tezepelumab 19
tigatuzumab 16
tildrakizumab 18
timolumab 10
tisotumab 4
tosatoxumab 29
tositumomab 25
tralokinumab 19
trastuzumab 20
tregalizumab 22
trevogrumab 11
ublituximab 26
urelumab 13
ustekinumab 22
utomilumab 23
vadastuximab 21
vadastuximab_talirin 21
vandortuzumab_vedotin 9
vantictumab 15
vanucizumab2 12
vanucizumab 20
varlilumab 11
vatelizumab 16
vedolizumab 18
veltuzumab 11
vesencumab 11
vorsetuzumab 15
vorsetuzumab_mafodotin 15
vunakizumab 25
xentuzumab 15
zatuximab 27
